BusinessGeneral NewsIndustryInternational

Glycomics/glycobiology Market 2020 Explosive Growth :Agilent Technologies, Bruker, Danaher, Merck KGaA, New England Biolabs, Agilent Technologies

A Professional Survey done by RFM has formulated a report titled “Glycomics/glycobiology Market”, which instills a crisp idea of the influential aspects affecting the growth of the Glycomics/glycobiology Market. It gives the new entrants a clear idea of all the business strategies incorporated by the key players, which is helping them regulate their trade success. It serves a reliable business tool helping the reader to understand the global and domestic scope of the Glycomics/glycobiology Market.

Some of the major competitors currently working in the Glycomics/glycobiology market are Agilent Technologies, Inc., Bruker, Danaher, Merck KGaA, New England Biolabs, Agilent Technologies, Inc, R&D Systems, Inc, Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Waters Corporation, Ludger Ltd and many others.

Get Sample Copy Of This Glycomics/glycobiology Market Report @  https://www.researchformarkets.com/sample/glycomics-glycobiology-market-620314

The growing demand for life-threatening diseases, such as cancer, has accelerated the pace of pharmaceutical and biotechnological R&D and overall expenditures. Research-driven sectors include glycomics (which are studied in the case of glycans) and proteomics (protein testing, which is a major factor in R&D glycomics). In addition, glycomic biomarkers have important uses in the development and diagnosis of drugs for diseases of this kind. As a consequence of this, that funding access for both sectors will in the next years support the growth of the industry in glycobiology.

  Glycomics/glycobiology market is expected to reach USD 4.38 billion by 2029 in the forecasted period of 2020-2029 with a health CAGR of 14.6%. The market is driven due to Increasing funding for proteomics & glycomics research and growing R&D expenditure in the forecasted period.

Glycomics/glycobiology market has been segmented on the basis product, application, and end user.

  • On the basis of product, the glycomics/glycobiology market is segmented into enzymes, instruments, kits, and reagents. Enzymes are further segmented into enzymes, glycosidases, glycosyltransferases, neuraminidases, sialyltransferases, other. Instruments are further segmented into antibody arrays, HPLC, lectin arrays, MALDI-TOF, mass spectrometers, other. Kits are further segmented into glycan labelling kits, glycan purification kits, glycan release kits, other. Reagents are further segmented into glycoproteins, monosaccharides, oligosaccharides, other reagents. The enzymes segment is expected to grow during the forecast period at the highest CAGR. Their consumables and broad use in a variety of testing and development procedures and in drug-discovery is the main reason for this rise.
  • On the basis of application, the glycomics/glycobiology market is segmented into diagnostics, drug discovery & development, oncology, immunology, other.

Now Get Instant 30% DISCOUNT on this Report @ https://www.researchformarkets.com/discount/glycomics-glycobiology-market-620314

Key Developments in the Glycomics/glycobiology Market :

  • In October 2019, S-Bio US launched an EZGlyco O-Glyan Prep Kit, an advanced research tool that allows scientists to produce glycoprotein O-glycans on a smooth, quick and reliable basis. S-BIO’s EZGlyco o-glycan package allows a fairly quick and reliable O-Glycan Analysis in support of current Biopharma initiatives. S-BIO’s latest O-Glyan Prep Package for HPLC and LC-Ms enabling glycoprotein characteristic analysis for biotherapy user’s uses non-toxic reactive and an easy procedure for processing, enriching, marking and purifying O-glycans in 5 hours.
  • In March 2019, ForteBio, the Biologics Business Unit of Molecular Devices, announced the availability of a new test kit for high-throughput glycan screening at the Bioprocess International (BPI) west conference in 2019. The GlyS package, developed for use on industry-leading Octet devices, provides a ground-breaking ability to faster, sooner in its production and with more tests than traditional methods for optimum sialylation. The GlyS Kit is part of the ForteBio process and product creativity promise to help better informed customers make choices faster, and that production cost and time.

Inquire here for more @

Table of Content: Glycomics/glycobiology Market 

Part 01: Executive Summary

Part 02: Scope of The Glycomics/glycobiology Market  Report

Part 03: Global Glycomics/glycobiology Market Landscape

Part 04: Global Glycomics/glycobiology Market Sizing

Part 05: Global Glycomics/glycobiology Market  Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Glycomics/glycobiology Market  Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Contact:

Mr. A Naidu

Research for Markets

Tel: +44 8000-4182-37 (UK)

Email: [email protected]

Close